18102-30-2

Basic information

• Product Name: 2amino-6-methylanisole
• Synonyms: 2amino-6-methylanisole;2-Methoxy-3-MethylbenzenaMine
• CAS NO: 18102-30-2
• Molecular Formula: C₈H₁₁NO
• Molecular Weight: 137.17904
• Mol File: 18102-30-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2amino-6-methylanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2amino-6-methylanisole(18102-30-2)
• EPA Substance Registry System: 2amino-6-methylanisole(18102-30-2)

Safety Data

• Hazardous Substances Data: 18102-30-2(Hazardous Substances Data)

Usage

Uses

2-Methoxy-3-methylaniline is an important building block.

Upstream product

• 13073-29-5 2-methyl-6-nitrophenol 
• 578-58-5 2-methylmethoxybenzene 
• 7647-01-0 hydrogenchloride 
• 103095-90-5 1-(2-methoxy-3-methyl-phenyl)-ethanone oxime 
• 18102-29-9 2-methyl-6-nitroanisole 

Downstream Products

• 25922-05-8 2-methyl-6-iodoanisole 
• 147807-80-5 2?hydroxy?3?methoxy?4?methylbenzaldehyde 
• 1449428-27-6 2-methoxy-3-methyl-N,N-bis(2-methoxyphenyl)-aniline 
• 25674-48-0 2-methoxy-1-methyl-3-(methylsulfanyl)benzene 
• 488-17-5 3-methylbenzene-1,2-diol 
• 861613-27-6 acetic acid-(2-methoxy-3-methyl-5-nitro-anilide) 
• 861613-25-4 acetic acid-(2-methoxy-3-methyl-6-nitro-anilide) 
• 861548-37-0 acetic acid-(2-methoxy-3-methyl-4-nitro-anilide) 
• 861609-39-4 2-methoxy-3-methyl-5-nitro-aniline 
• 861609-40-7 2-methoxy-3-methyl-4-nitro-aniline 
• 4837-88-1 6-methoxy-2-nitrotoluene 
• 50741-92-9 2-methyl-4-nitroanisole 
• 5460-31-1 3-nitro-o-cresol 

Relevant articles and documents

Total synthesis of the isoquinolinium metabolite ETM-204 of Trabectidin

Ecteinascidin-743 (Trabectidin, Trabectedin, Yondelis) is a synthetically obtained pharmaceutical drug originally isolated from a marine tunicate. Trabectedin is used for the chemotherapy of soft-tissue sarcoma and ovarian cancer. Th

COUMARIN DERIVATIVES AND METHODS OF USE IN TREATING CYSTIC FIBROSIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND MISFOLDED PROTEIN DISORDERS

Novel CFTR corrector compounds that are effective in rescuing halide efflux, delF508-CFTR protein processing, and apical functional chloride ion transport in a cell are provided. Also provided are methods for treating protein folding disorders (e.g., cyst

Amination of arenes with N,N-dimethyl-2-imidazolidinone O-methoxyacetyloxime

Treatment of nucleophilic arenes with N,N-dimethyl-2imidazolidinone O-methoxyacetyloxime and SnCl4 produced the corresponding N-arylimines, which were converted to anilines by hydrolysis with CsOH and to N-methylanilines by LiAlH4 reduction.